Table 1.
Prevalence of anal HPV types, overall and according to HIV status, among transwomen enrolled in the Transcender study, Rio de Janeiro, 2015 to 2016
| HPV type | Overall (N = 272) | HIV‐positive (N = 122) | HIV‐negative (N = 150) | p‐value |
|---|---|---|---|---|
| Any HPV type a | 212 (77.9) | 105 (86.1) | 107 (71.3) | <0.01 |
| Any 2‐valent vaccine types b | 61 (22.4) | 38 (31.1) | 23 (15.3) | <0.01 |
| Any 4‐valent vaccine types c | 101 (37.1) | 55 (45.1) | 46 (30.7) | 0.01 |
| Any 9‐valent vaccine types d | 139 (51.1) | 81 (66.4) | 58 (38.7) | <0.001 |
| Multiple HPV types e | 153 (72.2) | 90 (85.7) | 63 (58.9) | <0.001 |
| hr‐HPV f | ||||
| Any hr‐HPV types | 165 (60.7) | 92 (75.4) | 73 (48.7) | <0.001 |
| Multiple hr‐HPV types g | 96 (58.2) | 66 (71.7) | 30 (41.1) | <0.001 |
| HPV16 | 48 (17.6) | 27 (22.1) | 21 (14.0) | 0.08 |
| HPV18 | 16 (5.9) | 14 (11.5) | 2 (1.3) | <0.001 |
| HPV31 | 16 (5.9) | 12 (9.8) | 4 (2.7) | 0.01 |
| HPV33 | 22 (8.1) | 14 (11.5) | 8 (5.3) | 0.07 |
| HPV35 | 17 (6.2) | 14 (11.5) | 3 (2.0) | <0.01 |
| HPV39 | 39 (14.3) | 26 (21.3) | 13 (8.7) | <0.01 |
| HPV45 | 14 (5.1) | 11 (9.0) | 3 (2.0) | <0.01 |
| HPV51 | 31 (11.4) | 17 (13.9) | 14 (9.3) | 0.24 |
| HPV52 | 30 (11.0) | 17 (13.9) | 13 (8.7) | 0.17 |
| HPV56 | 34 (12.5) | 22 (18.0) | 12 (8.0) | 0.01 |
| HPV58 | 29 (10.7) | 23 (18.9) | 6 (4.0) | <0.001 |
| HPV59 | 25 (9.2) | 18 (14.8) | 7 (4.7) | <0.01 |
| HPV68 | 40 (14.7) | 23 (18.9) | 17 (11.3) | 0.08 |
| HPV73 | 9 (3.3) | 9 (7.4) | 0 (0.0) | <0.001 |
| HPV82 | 28 (10.3) | 19 (15.6) | 9 (6.0) | 0.01 |
| lr‐HPV | ||||
| HPV6 | 43 (15.8) | 21 (17.2) | 22 (14.7) | 0.57 |
| HPV11 | 21 (7.7) | 11 (9.0) | 10 (6.7) | 0.47 |
| HPV40 | 18 (6.6) | 11 (9.0) | 7 (4.7) | 0.15 |
| HPV42 | 42 (15.4) | 27 (22.1) | 15 (10.0) | 0.01 |
| HPV43 | 16 (5.9) | 7 (5.7) | 9 (6.0) | 0.93 |
| HPV44 | 64 (23.5) | 39 (32.0) | 25 (16.7) | <0.01 |
| HPV53 h | 35 (12.9) | 24 (19.7) | 11 (7.3) | <0.01 |
| HPV55 | 64 (23.5) | 39 (32.0) | 25 (16.7) | <0.01 |
| HPV66 h | 26 (9.6) | 14 (11.5) | 12 (8.0) | 0.33 |
| HPV70 | 24 (8.8) | 16 (13.1) | 8 (5.3) | 0.02 |
HIV, human immunodeficiency virus; HPV, human papillomavirus; hr‐HPV, high‐risk HPV; lr‐HPV, low‐risk HPV.
a
Positive for 1 + HPV type
b
HPV 16 or 18
c
HPV 6, 11, 16 or 18
d
HPV 6, 11, 16, 18, 31, 33, 45, 52 or 58
e
more than 1 HPV type (analysis restricted to those HPV positive, N = 212)
f
HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82
g
more than 1 hr‐HPV (denominator restricted to hr‐HPV‐positive, N = 165)
h
HPV 53 and 66 are currently considered as probable high‐risk types.